Enlivex (ENLV) Return on Capital Employed (2015 - 2025)
Enlivex (ENLV) posted quarterly Return on Capital Employed of 4.93% for Q4 2025, up 5877.0% year-over-year from 0.08% in Q4 2024, and up 93.76% quarter-over-quarter from 78.99% in Q3 2025.
Enlivex (ENLV) Return on Capital Employed (2015 - 2025) Analysis & Trends
Enlivex's Return on Capital Employed history runs 11 years deep, the most recent figure standing at 4.93% for Q4 2025.
- In Q4 2025, Return on Capital Employed rose 5877.0% year-over-year to 4.93%; the TTM figure through Dec 2025 stood at 4.93% (up 5877.0% YoY), while the FY2025 annual figure was 4.88%, up 5095.0% from the prior year.
- Return on Capital Employed for Q4 2025 stood at 4.93%, up from 78.99% in the prior quarter.
- The five-year high for Return on Capital Employed was 4.93% in Q4 2025, with the low at 88.24% in Q1 2024.
- The 5-year median for Return on Capital Employed is 48.57% (2023), against an average of 48.79%.
- The sharpest annual moves came in 2024 and 2025: Return on Capital Employed plunged 4340 bps in 2024, then surged 5877 bps in 2025.
- Enlivex's Return on Capital Employed stood at 20.98% in 2021, then sank by 94 bps to 40.68% in 2022, then plunged by 102 bps to 82.06% in 2023, then gained by 22 bps to 63.7% in 2024, then surged by 92 bps to 4.93% in 2025.
- Business Quant data shows ENLV's Return on Capital Employed at 4.93% in Q4 2025, 78.99% in Q3 2025, and 76.85% in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 20.76% |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 10.74% |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | -38.20% |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 13.68% |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 26.09% |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | -50.93% |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 7.88% |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | -6.85% |
| 10 | Enlivex | 4.58 Mn | -1.17 Mn | - | -4.93% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -4.93% |
| Sep 30, 2025 | -78.99% |
| Jun 30, 2025 | -76.85% |
| Mar 31, 2025 | -67.22% |
| Dec 31, 2024 | -63.70% |
| Sep 30, 2024 | -73.39% |
| Jun 30, 2024 | -80.67% |
| Mar 31, 2024 | -88.24% |
| Dec 31, 2023 | -82.06% |
| Sep 30, 2023 | -58.95% |
| Jun 30, 2023 | -52.30% |
| Mar 31, 2023 | -44.84% |
| Dec 31, 2022 | -40.68% |
| Sep 30, 2022 | -36.63% |
| Jun 30, 2022 | -30.41% |
| Mar 31, 2022 | -25.41% |
| Dec 31, 2021 | -20.98% |
| Sep 30, 2021 | -16.50% |
| Jun 30, 2021 | -14.58% |
| Mar 31, 2021 | -18.48% |